Lebwohl, M., Strober, B., Schrader, A., Li, A., Eckmann, T., Zhu, B., Malatestinic, W., Birt, J., Feely, M., & Blauvelt, A. (2023). 6-Month Real World Study to Assess the Effectiveness of Ixekizumab After Switching from IL-23 Inhibitors and Other Biologic Therapies: The CorEvitas Psoriasis Registry. SKIN The Journal of Cutaneous Medicine, 7(6), s232. https://doi.org/10.25251/skin.7.supp.232